262 related articles for article (PubMed ID: 26034533)
1. Isolation of different species of Candida in patients with vulvovaginal candidiasis from sari, iran.
Hedayati MT; Taheri Z; Galinimoghadam T; Aghili SR; Yazdani Cherati J; Mosayebi E
Jundishapur J Microbiol; 2015 Apr; 8(4):e15992. PubMed ID: 26034533
[TBL] [Abstract][Full Text] [Related]
2. Species Identification and Antifungal Susceptibility Pattern of Candida Isolates in Patients with Vulvovaginitis from Mymensingh, Bangladesh.
Sathi FA; Alam MM; Paul SK; Nasrin SA; Ahmed S; Haque N; Khan MS; Mamun AA; Khan S; Arafa P
Mymensingh Med J; 2023 Jul; 32(3):638-643. PubMed ID: 37391952
[TBL] [Abstract][Full Text] [Related]
3. Difference Between the Profiles Presented by Yeasts that Colonize the Vaginal Mucosa or Cause Primary or Recurrent Candidiasis.
Moreira D; Ruiz LS; Leite-Jr DP; Auler ME; Ramos RTB; Costa VT; Lara BR; Gasparetto A; Gandra RF; Melhem MSC; Paula CR
Mycopathologia; 2021 Jun; 186(3):411-421. PubMed ID: 34120275
[TBL] [Abstract][Full Text] [Related]
4. Fungal Profile of Vulvovaginal Candidiasis in a Tertiary Care Hospital.
Kalaiarasan K; Singh R; Chaturvedula L
J Clin Diagn Res; 2017 Mar; 11(3):DC06-DC09. PubMed ID: 28511380
[TBL] [Abstract][Full Text] [Related]
5. Comparison of enzymatic activities in different Candida species isolated from women with vulvovaginitis.
Fatahinia M; Halvaeezadeh M; Rezaei-Matehkolaei A
J Mycol Med; 2017 Jun; 27(2):188-194. PubMed ID: 28236530
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species.
Guzel AB; Ilkit M; Akar T; Burgut R; Demir SC
Med Mycol; 2011 Jan; 49(1):16-25. PubMed ID: 20608776
[TBL] [Abstract][Full Text] [Related]
7. Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis.
Ge G; Yang Z; Li D; Zhang N; Chen B; Shi D
Front Immunol; 2022; 13():959740. PubMed ID: 35967437
[TBL] [Abstract][Full Text] [Related]
8. Exoenzyme activity and possibility identification of Candida dubliniensis among Candida albicans species isolated from vaginal candidiasis.
Jafari M; Salari S; Pakshir K; Zomorodian K
Microb Pathog; 2017 Sep; 110():73-77. PubMed ID: 28642006
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Candida albicans, Candida dubliniensis and Candida africana in pregnant women suffering from vulvovaginal candidiasis in Argentina.
Mucci MJ; Cuestas ML; Landanburu MF; Mujica MT
Rev Iberoam Micol; 2017; 34(2):72-76. PubMed ID: 28385421
[TBL] [Abstract][Full Text] [Related]
10. Analysis of pathogenic factors of Candida albicans and the effect of vaginal immunization on recurrent vulvovaginal candidiasis in mice.
Shao MK; Qi WJ; Hou MY; Luo DD
J Obstet Gynaecol Res; 2022 Mar; 48(3):857-865. PubMed ID: 34970814
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite analysis of Candida isolates from recurrent vulvovaginal candidiasis.
Amouri I; Sellami H; Abbes S; Hadrich I; Mahfoudh N; Makni H; Ayadi A
J Med Microbiol; 2012 Aug; 61(Pt 8):1091-1096. PubMed ID: 22538998
[TBL] [Abstract][Full Text] [Related]
12. Virulence is one of the mechanisms of vulvovaginal candidiasis recurrence, rather than drug resistance.
Li X; Chen S; Lyu X; Tian J
Med Mycol; 2022 Nov; 60(11):. PubMed ID: 36328948
[TBL] [Abstract][Full Text] [Related]
13. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
14. Species Distribution and Antifungal Susceptibility Profiles of Isolates from Women with Nonrecurrent and Recurrent Vulvovaginal Candidiasis.
Rolo J; Faria-Gonçalves P; Barata T; Oliveira AS; Gaspar C; Ferreira SS; Palmeira-de-Oliveira R; Martinez-de-Oliveira J; Costa-de-Oliveira S; Palmeira-de-Oliveira A
Microb Drug Resist; 2021 Aug; 27(8):1087-1095. PubMed ID: 33646045
[TBL] [Abstract][Full Text] [Related]
15. Species spectrum and antifungal susceptibility profile of vaginal isolates of Candida in Kuwait.
Alfouzan W; Dhar R; Ashkanani H; Gupta M; Rachel C; Khan ZU
J Mycol Med; 2015 Mar; 25(1):23-8. PubMed ID: 25534676
[TBL] [Abstract][Full Text] [Related]
16. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana.
Adjapong G; Hale M; Garrill A
Med Mycol; 2017 Aug; 55(6):686-689. PubMed ID: 27838642
[TBL] [Abstract][Full Text] [Related]
17. Analysis of molecular resistance to azole and echinocandin in
Lotfali E; Erami M; Fattahi M; Nemati H; Ghasemi Z; Mahdavi E
Curr Med Mycol; 2022 Jun; 8(2):1-7. PubMed ID: 36654793
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
Fan SR; Liu XP; Li JW
J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
[TBL] [Abstract][Full Text] [Related]
19. An Update on the Roles of Non-
Makanjuola O; Bongomin F; Fayemiwo SA
J Fungi (Basel); 2018 Oct; 4(4):. PubMed ID: 30384449
[No Abstract] [Full Text] [Related]
20. Antifungal profile of vulvovaginal candidiasis in sexually active females from a tertiary care hospital of Western Rajasthan.
Kombade SP; Abhishek KS; Mittal P; Sharma C; Singh P; Nag VL
J Family Med Prim Care; 2021 Jan; 10(1):398-402. PubMed ID: 34017760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]